Lucas Vitzthum
@lukevitzthum
Followers
412
Following
704
Media
9
Statuses
76
Radiation Oncologist @StanfordRadOnc
Stanford, CA
Joined April 2014
RT @safaviaa: 🌟 Not all nails need the same 🔨 at the same ⏰: we must thoughtfully leverage our oncologic armamentarium for each pt. 🙏 Thank….
0
5
0
This figure shows the risk of bleeding by location and VEGFi status. Caveats are that this was delivered with highly conformal SABR and motion management. Still unclear what the optimal RT regimen is for ultracentral or if there is a safe washout period after VEGFi
A new study in the JTO from the Thoracic Rad Onc team demonstrates evidence of combined toxicity in patients receiving SABR and VEGF inhibitors. Toxicity is predominately observed in patients with ultra-central tumors. Link to study:
0
0
8
RT @BLoo_LT_SABR: @brianna_lau killing it at #WCLC2022 presenting secondary analysis of @StanfordRadOnc iSABR trial
0
5
0
RT @NRGonc: We are pleased to announce that Quynh-Thu Le, MD, @Qle_stanford, will serve as one of our Group Chairs effective July 1, 2021.….
0
21
0
RT @UCSanDiego: The moon perfectly aligned with @Scripps_Ocean Pier this morning 🌕. Photo by Erik Jepsen
0
83
0
RT @MaartenvSmeden: And another shoutout to @DominicComtois for creating the essential R library *summarytools*. view(dfSummary([your data….
0
14
0
This morning I had a P2P with @evicorehc to discuss a treatment that is supported by NCCN guidelines. The consulting MD never called and now we have to find a new time that works for them. Its frustrating to have so many barriers to advocate for your patient.
2
0
16
RT @StephenVLiu: #WCLC20 Updated data from KEYNOTE 799 presented by @MartinReck2 - pembrolizumab + chemoradiation in unresectable locally a….
0
22
0
RT @CharuAggarwalMD: New guidelines for vaccinating individuals with #Cancer with #COVID19 vaccines released by @NCCN . ✴️Vaccine is recomm….
0
136
0
An interesting new method to diagnose and potentially account for residual confounding using competing events out the @drlorenmell lab.
While this awaiting #peerreview thought I’d put this out there for #Epidemiology and #Biostatistics researchers: #BRACE method to help reduce bias in #Database / CER studies:
0
0
5
Excited to join the team!.
Excited to share the expansion of the @StanfordRadOnc Thoracic Radiation Oncology clinical service, to match the growth of the @StanfordCancer Thoracic Oncology program! Looking forward to pioneering more #RadOnc advances for our patients with #LungCancer. #LCSM
2
0
26
RT @Stanford: The #NobelPrize committee couldn't reach Paul Milgrom to share the news that he won, so his fellow winner and neighbor Robert….
0
24K
0
RT @ShakeKumarMD: 🧵My 1st *Tweetorial*! We investigated cost-effectiveness of adding SABR to standard tx for pts with oligometastatic dz. M….
0
28
0
RT @GWCancer: Please join us in welcoming Dr. Minh Huynh-Le as a new assistant professor of radiology in GW Radiation Oncology! We are exci….
0
6
0
RT @PBlanchardMD: Dr Le Péchoux @GustaveRoussy reports Lung ART trial #ESMO20. Post op 3D conformal #radiotherapy (54Gy) in pN2 NSCLC. ⬇️m….
0
32
0
RT @BarackObama: Everyone depends on the USPS. Seniors for their Social Security, veterans for their prescriptions, small businesses trying….
0
120K
0
Great work Abhishek! I'm excited to see what you will do at @DukeRadOnc.
Trying for the 1st time to tweet my research, so here it goes. *deep breath* Virtual #ASCO20 poster evaluating the cost-effectiveness of #SABR in oligometastatic cancer using SABR-COMET published data. TL;DR SABR very cost-effective under wide range of assumptions. @UCSDRadMed
1
1
8
I was ‘catfished’ today. And by that I mean an unknown number from my hometown area code sent me a picture of a giant catfish they caught.
1
0
19
RT @reneecrichlowMD: UMN medical school suspended classes UMN med students organize & take care of health providers kids so the Health care….
0
184
0
RT @drlorenmell: Great job @UCSDRadMed residents with project design, fun annual #parkcity research retreat tradition. Missed Dr Murphy t….
0
2
0